Caixin
Jul 26, 2018 07:39 PM
BUSINESS & TECH

Merck’s New Cancer Drug Wins Speedy Approval in China

The corporate headquarters of Merck & Company Inc. are seen in Kenilworth, New Jersey, on May 1. Photo: IC
The corporate headquarters of Merck & Company Inc. are seen in Kenilworth, New Jersey, on May 1. Photo: IC

Pharmaceutical giant Merck Sharp & Dohme (MSD) has won approval to launch a cutting-edge cancer drug in China, a month after rival Bristol-Myers Squibb (BMS) obtained the go-ahead for its own such drug.

The MSD medicine, Keytruda, received the green light from the China Food and Drug Administration (CFDA) on Wednesday. The drug can cure certain levels of melanoma, a type of skin cancer.

ladingImg
You've accessed an article available only to subscribers
Try 4 weeks for $0.99
SUBSCRIBE
Share this article
Open WeChat and scan the QR code
Copyright © 2017 Caixin Global Limited. All Rights Reserved.